Subscribe to MDT Magazine News

New Data for Engineering Immune Cells Shows Early Promise in Solid Tumors

December 20, 2013 10:00 am | by AACR | Comments

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior...


BioTime Reports Isolation of Novel Brain-Associated Cells From Human Embryonic Stem Cells

December 20, 2013 9:00 am | by Business Wire | Comments

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine reported today the publication of a peer-reviewed scientific paper on the successful generation of human cells with markers of...


Study Shows Robotic-Assisted Prostate Surgery Reduces Hospital Readmission and Complication Rates Compared to Open Surgery

December 19, 2013 8:45 pm | by GlobeNewswire | Comments

A national, multi-institutional database study found readmission and complication rates were significantly lower for robotic-assisted prostate surgery than for open prostate surgery. The full study results were published in the November 19...


AtriCure Announces Definitive Agreement to Acquire Estech

December 19, 2013 4:05 pm | by Business Wire | Comments

AtriCure, Inc., a leading Atrial Fibrillation medical device provider, and Endoscopic Technologies, Inc. d/b/a Estech, today announced that they have entered into a definitive merger agreement under which AtriCure has agreed to acquire Estech...


MRI Method for Measuring MS Progression Validated

December 19, 2013 3:36 pm | by University of Western Ontario | Comments

New imaging research from Western University (London, Canada) has demonstrated that a magnetic resonance imaging (MRI) approach called quantitative susceptibility mapping (QSM) can be an important tool for diagnosing and tracking the progression...


DNA Clamp to Grab Cancer Before It Develops

December 19, 2013 3:34 pm | by Université de Montréal | Comments

As part of an international research project, a team of researchers has developed a DNA clamp that can detect mutations at the DNA level with greater efficiency than methods currently in use. Their work could facilitate rapid screening of...


Plant-Based ‘Microswimmers’ Could Propel Drugs to the Right Location

December 19, 2013 3:24 pm | by American Chemical Society | Comments

In the quest to shrink motors so they can maneuver in tiny spaces like inside and between human cells, scientists have taken inspiration from millions of years of plant evolution and incorporated, for the first time, corkscrew structures from...


pSivida, Alimera Sciences soar as Iluvien skips ahead to FDA review

December 19, 2013 1:58 pm | by Mass Device | Comments

Massachusetts-based pSivida is making a comeback, with shares soaring on news that the company and its licensee Alimera Sciences will get to skip past the advisory panel committee meeting and head straight to final FDA review for the Iluvien...


Xlumena wins FDA nod for Axios pancreatic stent

December 19, 2013 1:54 pm | by Mass Device | Comments

Xlumena won FDA approval to market its Axios stent and delivery system, landing approval through the FDA's less-stringent de novo review pathway. The stent is the 1st specifically designed for the drainage of a pancreatic pseudocyst by creating...


Short-seller takes another shot at Mindray Medical

December 19, 2013 1:41 pm | by Mass Device | Comments

Short-seller Ottoman Bay Research took another shot at Mindray Medical this week, taking issue with the Chinese medical device company's response to Ottoman's initial accusations of fraud and mismanagement. MR shares lost 11% Dec. 12 after...

Genstar Capital Announces Acquisition of Tecomet

December 19, 2013 1:40 pm | by The Associated Press | Tecomet | Comments

Genstar Capital Management, LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, healthcare, financial services, and software industries, announced today the acquisition of Tecomet...

Medifocus brings in $3.5M via debt financing

December 19, 2013 1:29 pm | by Mass Device | Comments

Medifocus said it brought in $3.5 million in a private offering of convertible debt, a raise tied to company's August non-brokered private placement of $6 million. The $3.5 million came from 354 redeemable promissory notes priced at $10,000...

World's First Implant After FDA Approval for Groundbreaking Epilepsy Treatment

December 19, 2013 12:39 pm | by The Associated Press | Comments

On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration (FDA) to treat epilepsy, with potential to help millions of people worldwide...


ZipLine® Medical Clinical Study Data Presented at Mt. Sinai “Winter Symposium”: ZipLine Produces Suture-Like Outcomes with Significant Surgical Time-Savings

December 19, 2013 11:29 am | by Business Wire | Comments

Preliminary clinical study results from a randomized, controlled, prospective clinical study comparing the ZipLine Surgical Skin Closure to traditional stitches for skin cancer excision were presented at the 16th Annual Mount Sinai Winter Symposium...


UCLA Researcher Highlights Advances in Nanotechnology's Fight Against Cancer

December 19, 2013 11:13 am | by University of California - Los Angeles | Comments

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.